Labcorp Plasma Focus Liquid Biopsy Test Launches
Labcorp has launched Labcorp Plasma Focus, a new liquid biopsy test enabling targeted therapy selection for solid tumors.
Read MorePosted by Chris Wolski | Jun 1, 2023 | Cancer |
Labcorp has launched Labcorp Plasma Focus, a new liquid biopsy test enabling targeted therapy selection for solid tumors.
Read MorePosted by Melanie Hamilton-Basich | Apr 28, 2023 | Uncategorized |
Generalist medical AI models can integrate multiple data types — such as MRI scans, X-rays, blood test results, medical texts, and genomic testing — to perform a range of tasks
Read MorePosted by Andy Lundin | Apr 7, 2023 | Unknown Origin & Other Cancer Types |
A simple blood draw can help determine if peptide receptor radionuclide therapy is effective in a patient with neuroendocrine cancer.
Read MorePosted by Andy Lundin | Apr 4, 2023 | Cancer |
Stilla Technologies and Atila BioSystems agreed to market digital PCR kits and assays produced by Atila for use on Stilla’s naica system.
Read MorePosted by Andy Lundin | Mar 27, 2023 | Cancer |
SEngine has been certified through the NY State Department of Health’s CLEP program to perform the PARIS Test on samples from the state.
Read More